Scholarly Index
Robert J. Konrad
Eli Lilly (United States); 8,832 total citations; 178 total publications; best world rank #58
Eli Lilly (United States)
8,832Total citations
178Total publications
51H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Biosimilars and Bioanalytical Methods | Lifetime | 326 | US 116 | 94.87 |
| Lipoproteins and Cardiovascular Health | Lifetime | 951 | US 380 | 96.50 |
| Lipid metabolism and disorders | Lifetime | 617 | US 230 | 94.00 |
| Lipid metabolism and disorders | 2021-2025 | 58 | US 22 | 92.87 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 405 | US 103 | 91.46 |